Results 251 to 260 of about 55,987 (284)

[New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].

, 2007
Itsuro Endo, Toshio Matsumoto
openalex  

Some of the next articles are maybe not open access.

Related searches:

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein, Amit M Oza   +2 more
exaly  

Osteoporosis, bone mineral density and CKD–MBD: treatment considerations

JN. Journal of Nephrology (Milano. 1992), 2017
J. Bover, Lucía Bailone, Víctor López-Báez, Silvia Benito, P. Ciceri, A. Galassi, M. Cozzolino   +6 more
semanticscholar   +1 more source

[New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Itsuro, Endo, Toshio, Matsumoto
openaire   +1 more source

[New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].

, 2007
Masataka Shiraki
openalex  

[New bone density conservation agents for osteoporosis under research and development: Anti-RANKL antibody].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Seiki, Wada, Takeshi, Fukawa, Sadahiro, Kamiya   +2 more
openaire   +1 more source

[New bone density conservation agents for osteoporosis under research and development: ED-71].

, 2007
Hiroshi Hagino
openalex  

[New bone density conservation agents for osteoporosis under research and development: Zoledronate].

, 2007
Seiki Wada, Takeshi Fukawa, Sadahiro Kamiya   +2 more
openalex  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Antiresorptive and anabolic agents in the prevention and reversal of bone fragility

Nature Reviews Rheumatology, 2019
Ego Seeman, Ego Seeman, Thomas J. Martin
semanticscholar   +1 more source